Failure to Thrive
21
0
0
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
9.5%
2 terminated out of 21 trials
87.5%
+1.0% vs benchmark
10%
2 trials in Phase 3/4
7%
1 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (21)
Leveraging Optimal Tolerance in Undernourished Infants to Support Growth
Pediatric GI Endoscopy at Assiut University
Role of Gastroinestinal Endoscopy in Pediatric Failure to Thrive
High Calorie Formula Intervention on Weight, Length Increment, Total Lymphocyte Counts, TNF-alpha and IGF-1 in Failure to Thrive Children
Impact of Home Weight Tele-monitoring on the Number of Office Visits in the First Six Weeks of Life in Infants.
Biomarker for Cystic Fibrosis
The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
Nasogastric Tube Securement Comparison Study
Trial of Home Visitation Among Infants With Failure To Thrive
Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients
Mobile-Thrive - A Family Self-Management Approach to Failure to Thrive
Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children
Appetite Regulation in Children With Failure to Thrive
Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
Ghrelin Levels in Children With Poor Growth
Clinical Tolerance of Numeta 13%
Cyproheptadine as an Appetite Stimulant
Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome
Evaluation of Patients With Unresolved Chromosome Abnormalities